Skip to content

Formulated muco-regulatory agents in the airways of patients with cystic fibrosis

Project: Research

  1. 2008
  2. Published

    Cospray-dried unfractionated heparin with L-leucine as a dry powder inhaler mucolytic for cystic fibrosis therapy

    J. Shur, Tom Nevell, R. Ewen, R. Price, Andrew Smith, Eugen Barbu, J. Conway, M. Carroll, Professor Janis Kay Shute & Dr James Smith, 2008, In : Journal of Pharmaceutical Sciences. 97, 11, p. 4857-4868 12 p.

    Research output: Contribution to journalArticle

  3. Published

    The spray drying of unfractionated heparin: optimization of the operating parameters

    J. Shur, Tom Nevell, Professor Janis Kay Shute & Dr James Smith, 2008, In : Drug Development and Industrial Pharmacy. 34, 6, p. 559-568 10 p.

    Research output: Contribution to journalArticle

  4. 2007
  5. Published

    Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics

    V. Broughton-Head, Dr James Smith, J. Shur & Professor Janis Kay Shute, Dec 2007, In : Pulmonary Pharmacology & Therapeutics. 20, 6, p. 708-717 10 p.

    Research output: Contribution to journalArticle

  6. Published

    Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis

    V. Broughton-Head, J. Shur, M. Carroll, Dr James Smith & Professor Janis Kay Shute, 2007, In : American Journal of Physiology: Lung, Cellular and Molecular Physiology. 293, 5, p. L1240-L1249

    Research output: Contribution to journalArticle

ID: 3904982